NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
Active, not recruiting · NCT04623944 · Registry updated 2024-12-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2024-12-27 | NCT04623944 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nkarta, Inc. | 5 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | United States | 178 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| MD Anderson Cancer Center, University of Texas | Houston | United States | 1 |
| Methodist Healthcare System of San Antonio | San Antonio | United States | 4 |
| Sarah Cannon at TriStar Bone Marrow Transplant Center | Nashville | United States | 1 |
| The Cleveland Clinic - Taussig Cancer Institute | Cleveland | United States | 1 |
| University of Chicago Medical Center | Chicago | United States | 152 |
| Winship Cancer Institute, Emory University | Atlanta | United States | 47 |